State of Wyoming’s Aurinia Pharmaceuticals AUPH Stock Holding History

State of Wyoming’s Portfolio AUPH Stock Details AUPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$230K	Sell	13,528 -13,941	-51%	-$223K	0.02%	899
2026 Q1	$407K	Sell	27,469 -5,214	-16%	-$76.2K	0.05%	469
2025 Q4	$521K	Sell	32,683 -5,019	-13%	-$71.1K	0.06%	348
2025 Q3	$417K	Buy	37,702 +9,396	+33%	+$103K	0.05%	436
2025 Q2	$240K	Buy	+28,306	New	+$227K	0.03%	789
2022 Q1	–	Sell	-28	Closed	-$1K	–	1791
2021 Q4	$1K	Sell	28 -35	-56%	-$829	﹤0.01%	1796
2021 Q3	$1K	Buy	+63	New	+$1K	﹤0.01%	1169

Other funds holding AUPH

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of Wyoming's AUPH Position: Q2 2026 in Review

State of Wyoming reduced its Aurinia Pharmaceuticals (AUPH) stake by 51% in Q2 2026, selling an estimated $223K and leaving 13,528 shares worth $230K. The position accounts for 0.02% of the portfolio, ranked #899.

State of Wyoming first reported a position in AUPH in Q3 2021 and has held it in 7 quarters since. The position peaked at $521K in Q4 2025. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

State of Wyoming held 13,528 shares of Aurinia Pharmaceuticals worth $230K as of Q2 2026.
State of Wyoming sold 13,941 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $223K.
Aurinia Pharmaceuticals made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #899 holding.
State of Wyoming first reported a position in Aurinia Pharmaceuticals in Q3 2021 and has held it in 7 quarters since.
State of Wyoming's Aurinia Pharmaceuticals position peaked at $521K in Q4 2025.
282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.